Facilitation of rapid-sequence intubation with large-dose vecuronium with or without priming. 1992

K Deepika, and G B Bikhazi, and H M Mikati, and M Namba, and F F Foldes
Department of Anesthesiology, University of Miami School of Medicine, FL 33101.

OBJECTIVE To determine the effect of priming on the intubation and onset times of vecuronium 0.3 mg/kg. METHODS Randomized, unblinded study. METHODS Operating rooms and postanesthetic recovery unit of a university-affiliated general hospital. METHODS Thirty female ASA physical status I and II patients scheduled for intraperitoneal surgery divided into two groups of 15 each. METHODS Anesthesia was induced and maintained with sufentanil, droperidol, thiopental sodium, and nitrous oxide in oxygen. Patients in Group 1 were given vecuronium 0.015 mg/kg 4 minutes before induction and vecuronium 0.285 mg/kg 1 minute after induction. Patients in Group 2 received a single 0.3 mg/kg dose of vecuronium 1 minute after thiopental sodium. The ulnar nerve was stimulated every 10 seconds with train-of-four supramaximal impulses of 0.2 millisecond duration at 2 Hz. The compound electromyogram (EMG) of the adductor pollicis was continuously recorded. The trachea was intubated when the amplitude of the EMG decreased to 15% to 25% of control. At the end of surgery, residual neuromuscular block was reversed with edrophonium 0.75 mg/kg. RESULTS All patients in Group 1 could be intubated in 80 seconds or less, and the longest onset time was 120 seconds. In Group 2, the longest intubation time was 140 seconds, and the longest onset time was 200 seconds. Clinical durations in both groups were unpredictable, ranging from 47 to 185 minutes in Group 1 and from 63 to 160 minutes in Group 2. Ten of the 30 patients required an additional 0.5 mg/kg of edrophonium for antagonism of the residual neuromuscular block. There were no significant changes in heart rate or blood pressure attributable to vecuronium. CONCLUSIONS Seventy-five percent to 85% neuromuscular block of the adductor pollicis, required for atraumatic tracheal intubation, developed in 80 seconds or less when vecuronium 0.3 mg/kg was administered in divided doses and in 140 seconds or less when it was injected as a single bolus dose. Clinical duration of vecuronium 0.3 mg/kg is long and unpredictable, and reversal of residual neuromuscular block may require larger doses of anticholinesterases. It is recommended that an intubating dose of vecuronium 0.3 mg/kg be used only in patients undergoing long surgical procedures that require prolonged postanesthetic mechanical ventilation.

UI MeSH Term Description Entries
D007442 Intubation, Intratracheal A procedure involving placement of a tube into the trachea through the mouth or nose in order to provide a patient with oxygen and anesthesia. Intubation, Endotracheal,Endotracheal Intubation,Endotracheal Intubations,Intratracheal Intubation,Intratracheal Intubations,Intubations, Endotracheal,Intubations, Intratracheal
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014673 Vecuronium Bromide Monoquaternary homolog of PANCURONIUM. A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for elimination as well as its short duration of action and easy reversibility provide advantages over, or alternatives to, other established neuromuscular blocking agents. NC-45,Norcuron,ORG-NC 45,ORG-NC-45,ORG-NC45,Vecuronium,Vecuronium Bromide, Quaternary Ion,Vecuronium Citrate,Vecuronium Hydrobromide,Vecuronium Hydrochloride,Vecuronium Maleate,Vecuronium Phosphate,Bromide, Vecuronium,Citrate, Vecuronium,Hydrobromide, Vecuronium,Hydrochloride, Vecuronium,Maleate, Vecuronium,NC 45,NC45,ORG NC 45,ORG NC45,ORGNC 45,ORGNC45,Phosphate, Vecuronium

Related Publications

K Deepika, and G B Bikhazi, and H M Mikati, and M Namba, and F F Foldes
March 1993, Ma zui xue za zhi = Anaesthesiologica Sinica,
K Deepika, and G B Bikhazi, and H M Mikati, and M Namba, and F F Foldes
September 1987, Pediatric emergency care,
K Deepika, and G B Bikhazi, and H M Mikati, and M Namba, and F F Foldes
April 1986, Anesthesiology,
K Deepika, and G B Bikhazi, and H M Mikati, and M Namba, and F F Foldes
April 1985, Anesthesiology,
K Deepika, and G B Bikhazi, and H M Mikati, and M Namba, and F F Foldes
November 1994, Acta anaesthesiologica Scandinavica,
K Deepika, and G B Bikhazi, and H M Mikati, and M Namba, and F F Foldes
December 1996, Journal of anesthesia,
K Deepika, and G B Bikhazi, and H M Mikati, and M Namba, and F F Foldes
October 1987, British journal of anaesthesia,
K Deepika, and G B Bikhazi, and H M Mikati, and M Namba, and F F Foldes
January 1987, Revista espanola de anestesiologia y reanimacion,
K Deepika, and G B Bikhazi, and H M Mikati, and M Namba, and F F Foldes
January 1987, Revista espanola de anestesiologia y reanimacion,
K Deepika, and G B Bikhazi, and H M Mikati, and M Namba, and F F Foldes
March 1985, Ma zui xue za zhi = Anaesthesiologica Sinica,
Copied contents to your clipboard!